Nonmotor Manifestations in Parkinson Disease

Depression in Parkinson's Disease

(2014) Barbara Jasinska-Myga et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation

(2011) L. B. Zahodne et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida

(2010) Frederic N. Nguyen et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The Relationship Between Anosmia, Constipation, and Orthostasis and Parkinson's Disease Duration: Results of a Pilot Study

(2010) Amit L. Ramjit et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Is Rhinorrhea an Under-Recognized Intrinsic Symptom of Parkinson Disease? A Prospective Pilot Study

(2010) Laura Sedig et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists

(2010) Karina L. Bienfait et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole

(2010) Naoto Kohno et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

(2010) Wayne A. Hening et al.   MOVEMENT DISORDERS

Rhinorrhea: A common nondopaminergic feature of Parkinson's disease

(2010) Kelvin L. Chou et al.   MOVEMENT DISORDERS

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease

(2010) Joseph H. Friedman et al.   MOVEMENT DISORDERS

Sialorrhea and Parkinson disease—novel treatment approaches

(2010) Michelle S. Troche et al.   Nature Reviews Neurology

Gum chewing improves swallow frequency and latency in Parkinson patients: A preliminary study

(2010) A. R. South et al.   NEUROLOGY

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

(2010) J. C. Klein et al.   NEUROLOGY

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

(2010) R. B. Postuma et al.   NEUROLOGY

Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial

(2010) M. E. L. Arbouw et al.   NEUROLOGY

Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors

(2010) Valerie Voon et al.   NEURON

A meta-analysis of performance on emotion recognition tasks in Parkinson’s disease.

(2010) Heather M. Gray et al.   NEUROPSYCHOLOGY

The impact of and the factors associated with drooling in Parkinson's disease

(2010) Joshua Leibner et al.   PARKINSONISM & RELATED DISORDERS

Long term follow-up of Parkinson's disease patients with impulse control disorders

(2010) Melis Sohtaoğlu et al.   PARKINSONISM & RELATED DISORDERS

Prevalence and Characteristics of Alexithymia in Parkinson's Disease

(2010) A. Costa et al.   PSYCHOSOMATICS

Cost-Effectiveness of Duloxetine: The Stress Urinary Incontinence Treatment (SUIT) Study

(2010) Borislava Mihaylova et al.   VALUE IN HEALTH

Hyposialorrhea as an early manifestation of Parkinson disease

(2009) M.G. Cersósimo et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

A clinico-pathological study of subtypes in Parkinson's disease

(2009) M. Selikhova et al.   BRAIN

Using Modafinil to Treat Fatigue in Parkinson Disease

(2009) Jau-Shin Lou et al.   CLINICAL NEUROPHARMACOLOGY

Dopamine Dysregulation Syndrome

(2009) Sean S. OʼSullivan et al.   CNS DRUGS

Behavioural Adverse Effects of Dopaminergic Treatments in Parkinsonʼs Disease

(2009) Angelo Antonini et al.   DRUG SAFETY

Pathophysiology and Treatment of Psychosis in Parkinson’s Disease

(2009) Laura B Zahodne et al.   DRUGS & AGING

Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson’s disease

(2009) Naroa Ibarretxe-Bilbao et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

S.19.05 Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease

(2009) I. Arnulf   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Rivastigmine in Parkinson's disease dementia

(2009) Shilpa Chitnis et al.   Expert Opinion on Drug Metabolism & Toxicology

Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia

(2009) Taher Darreh-Shori et al.   Expert Opinion On Drug Safety

Depressive Symptoms in Parkinson Disease Correlate With Impaired Global and Specific Cognitive Performance

(2009) Hubert H. Fernandez et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Modafinil for Parkinson’s disease fatigue

(2009) Hilary L. Tyne et al.   JOURNAL OF NEUROLOGY

Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling

(2009) Giovanni Lagalla et al.   JOURNAL OF NEUROLOGY

Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study

(2009) Kenn Freddy Pedersen et al.   JOURNAL OF NEUROLOGY

Formation and development of Lewy pathology: a critical update

(2009) Kurt A. Jellinger   JOURNAL OF NEUROLOGY

Non-motor symptoms in Parkinson’s disease

(2009) Ariane Park et al.   JOURNAL OF NEUROLOGY

Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study

(2009) K F Pedersen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

(2009) U. Ehrt et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Anxiety, Depression, and Quality of Life in Parkinson's Disease

(2009) R. Quelhas et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Listener impressions of speakers with Parkinson’s disease

(2009) ABHISHEK JAYWANT et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Cardiovascular autonomic dysfunction in Parkinson's disease

(2009) Tjalf Ziemssen et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy

(2009) Antonella Giannantoni et al.   JOURNAL OF UROLOGY

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

(2009) Valerie Voon et al.   LANCET NEUROLOGY

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

Fatigue in Japanese patients with Parkinson's disease: A study using Parkinson fatigue scale

(2009) Yasuyuki Okuma et al.   MOVEMENT DISORDERS

Major nutritional issues in the management of Parkinson's disease

(2009) Michela Barichella et al.   MOVEMENT DISORDERS

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

(2009) Holger Honig et al.   MOVEMENT DISORDERS

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

(2009) Iracema Leroi et al.   MOVEMENT DISORDERS

Psychotic and compulsive symptoms in Parkinson's disease

(2009) Dagmar Verbaan et al.   MOVEMENT DISORDERS

Orthostatic hypotension, balance and falls in Parkinson's disease

(2009) Maarit Matinolli et al.   MOVEMENT DISORDERS

Weight loss, body fat mass, and leptin in Parkinson's disease

(2009) Birgitta Lorefält et al.   MOVEMENT DISORDERS

Restless legs syndrome in Parkinson's disease

(2009) Cecilia M. Peralta et al.   MOVEMENT DISORDERS

Progression of dysprosody in Parkinson's disease over time-A longitudinal study

(2009) Sabine Skodda et al.   MOVEMENT DISORDERS

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

(2009) E. Y. Uc et al.   NEUROLOGY

Biphasic effect of apomorphine, an anti-parkinsonian drug, on bladder function in rats

(2009) T. Uchiyama et al.   NEUROSCIENCE

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

(2009) Roberto Ceravolo et al.   PARKINSONISM & RELATED DISORDERS

Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics

(2009) Ann B. Sollinger et al.   PARKINSONISM & RELATED DISORDERS

Impulsive choice and response in dopamine agonist-related impulse control behaviors

(2009) Valerie Voon et al.   PSYCHOPHARMACOLOGY

Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study

(2009) James Wang et al.   SLEEP MEDICINE

Voice onset time in Parkinson disease

(2009) Emily Fischer et al.   JOURNAL OF COMMUNICATION DISORDERS

Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control

(2009) Michael J. Hammer et al.   EXPERIMENTAL BRAIN RESEARCH

Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease

(2008) William G. Ondo et al.   ARCHIVES OF NEUROLOGY

The impact of Parkinson’s disease on sequence learning: Perceptual pattern learning and executive function

(2008) Amanda Price et al.   BRAIN AND COGNITION

Prevalence of orthostatic hypotension

(2008) Phillip A. Low   CLINICAL AUTONOMIC RESEARCH

Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease

(2008) Irena Rektorova et al.   CLINICAL NEUROPHARMACOLOGY

Open-Label Study Assessment of Safety and Adverse Effects of Subcutaneous Apomorphine Injections in Treating "Off" Episodes in Advanced Parkinson Disease

(2008) Peter A. LeWitt et al.   CLINICAL NEUROPHARMACOLOGY

Sialorrhoea and Drooling in Patients with Parkinson’s Disease

(2008) Marcelo Merello   DRUGS & AGING

Impact of fatigue on quality of life in patients with Parkinson’s disease

(2008) E. Havlikova et al.   EUROPEAN JOURNAL OF NEUROLOGY

Pedunculopontine nucleus stimulation influences REM sleep in Parkinson’s disease

(2008) A. Romigi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin

(2008) G. G. Kay et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Neuropsychiatric symptoms three years after subthalamic DBS in PD patients

(2008) Lorys Castelli et al.   JOURNAL OF NEUROLOGY

A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease

(2008) J Grace et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Loss of Libido in Parkinson's Disease

(2008) Arthur Kummer et al.   Journal of Sexual Medicine

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

(2008) Claudia Trenkwalder et al.   LANCET NEUROLOGY

Management of neurogenic orthostatic hypotension: an update

(2008) Phillip A Low et al.   LANCET NEUROLOGY

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

(2008) David Devos et al.   MOVEMENT DISORDERS

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

(2008) Jaime Kulisevsky et al.   MOVEMENT DISORDERS

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS

Neural control of the gastrointestinal tract: Implications for Parkinson disease

(2008) Maria G. Cersosimo et al.   MOVEMENT DISORDERS

Clinical correlates of depressive symptoms in familial Parkinson's disease

(2008) Nathan Pankratz et al.   MOVEMENT DISORDERS

Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice

(2008) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

Manifestations of Parkinson disease differ in association with REM sleep behavior disorder

(2008) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Sertraline in the treatment of depressive disorders in patients with Parkinson’s disease

(2008) Silvia Marino et al.   NEUROLOGICAL SCIENCES

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY

Rhinorrhea is increased in Parkinson's disease

(2007) Joseph H. Friedman et al.   MOVEMENT DISORDERS

The relationship between impulsivity and impulse control disorders in Parkinson's disease

(2007) Ioannis U. Isaias et al.   MOVEMENT DISORDERS

For better or worse: The effect of levodopa on speech in Parkinson's disease

(2007) Aileen K. Ho et al.   MOVEMENT DISORDERS

A validation study of depressive syndromes in Parkinson's disease

(2007) Sergio E. Starkstein et al.   MOVEMENT DISORDERS

An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin−/− mice and patients

(2007) Jian-Sheng Lin et al.   NEUROBIOLOGY OF DISEASE